• Home
• Attendees
  • General information
  • Attendess cost
• Exhibitors
  • General information
  • Booth Exhibitors INFO
  • Poster Presenters INFO
  • R&D Project
  • Scientific Services
  • Companies
  • Institutions
• BioPartnering
  • General information
  • BioPartnering cost
• Lectures & Seminars
  • General plan
  • Plan in details
  • Wednesday plan
  • Thursday plan
  • Friday - Satelite Workshop only
• Press
  • General information
  • Press releases
  • Graphic Materials
  • Media Partners
  • Accreditation form
• Registration
  • Costs of participation
  • Registration Form - More information
  • NEW REGISTRATION
  • Account settings

Wednesday plan - printable version

Wednesday (June 3^rd, 2009)

9:00 - 09:15	Opening ceremony
9:15 - 10.00	Morning Keynote Lecture
	Artur Chabowski, ACADIA Artur Chabowski S.K.A. - Fund raising for biotech enterprises in Central Europe more... Mr. Artur Chabowski, financial adviser, with over 15 years experience in investment banking, specializing in mergers and acquisitions in Central and Eastern Europe. He has been working for the Ministry of Privatization, CAIB Financial Advisers, ABN AMRO and KPMG. Since 2004, an independent financial adviser and private equity investor. Owner of ACADIA S.K.A, an Authorized Adviser at New Connect on Warsaw Stock Exchange. He graduated from Warsaw University of Technology, and done his postgraduate studies at Woodrow Wilson School of Public and International Affairs at Princeton University. hide...
10.15 - 11.45	Hungarian Biotech - seminar of Hungarian Biotechnology Association
	Monika Jankovics, The Association and the Hungarian biotechnology - overview. Hungarian Biotechnology Association. more... Monika Jankovics is a Project Manager at the Hungarian Biotechnology Association. She received her Diploma (M.Sc.) in English Language and Literature and she has also completed the Teacher Training Track, both in 2005 at the University of Szeged. Her current tasks are preparation and management of national and international grant proposals and projects, organizing various events and conferences, administration, communication and coordination of matters involving the interest of the Association. hide...
	Gabriella Fabian, Ph.D ., Senior Scientist, Target identification of drug molecues for pharmaceutical development Ltd.more... Dr. Gabriella Fabian graduated in biology from the Attila University in Szeged, Faculty of Natural Sciences. She obtained her PhD at Szeged University, Doctoral School of Theoretical Medical Sciences. She has a broad experience both as a researcher as well as marketing manager. Presently Dr. Fabian holds a Senior research scientist position at Avicor Ltd. Senior Project Manager, Hungarian Biotechnology Association Mr Ordogh currently holds the position of Project Manager at the Hungarian Biotechnology Association. Between 2005 and 2008 he occupied the position of Project Manager at DARF� (South-Plain Regional Development Agency). During the time spent there he was part of the international work group of the region and he has participated in a number of international projects - chiefly involving other members of the European Union. With his work he contributed to the sustainable economical development of the region (INTERREG III C projects) and to the promotion of the regional technological transfer (FP 6) Previously he worked at Szatymaz Local Government as Project Manager. His main tasks were managing tenders involving overall development of the settlement. Between 2002 and 2004 he was working as a Project Manager in the micro-regional office in M�rahalom, where he dealt with projects enhancing the economic development of settlements of the micro region. In the absence of the CEO, Mr Ordogh attended also the management tasks of the office. In 2004 he was given the opportunity to participate in the Minnesota Agricultural Student Trainee program (MAST) as an exchange student. During the time spent in the United States he perfected his knowledge of English language and he also established good relations with the other participants of the program. Antal Ordogh earned his degree in agricultural engineering at the Szent Istvan University in G�d�llo, Hungary. His Thesis and chosen field was rural and spatial development and also professional consulting. Avicor tries to fill a gap between chemistry and genomics by using a proprietary platform, called chemical microarrays. Chemical microarrays are novel products for providing powerful tools for pharma and biotech sphere. The essence of the AviLinkTM technology is a surface chemical modification strategy that allows for the immobilization of a very wide range of compounds. This approach does not require insertion a specific functionalized linker arm, therefore, it omits chemical synthesis of compounds with linkers. This technology enables us to screen tens of thousands of drug-like molecules in hours if we have a potential drug target without preestablished and optimized screens. The same platform can be used for differential proteome screening for identification of new disease targets. This bead-based affinity chromatography followed by protein identification by MS method has been successfully applied to kinase selectivity profiling and the discovery of the novel targets for lead compounds developed using cell-based phenotypic screens (REF1-3). We produce and provide powerful tools: standard Avi-ChemixTM Chemical Microarrays - as products and different services built around it, and we plan to expand our product portfolio with thematic chemical microarrays with which we intend to create a new market with a unique product and service technology portfolio. hide...
	Agoston Miklos , Special disposables for manipulation, storage and transportation for big amount of small volume samples - Tomtec Plasctics Kft. more... Tomtec Plastics Ltd is a Hungarian biotechnological company. We developed and manufacture some consumables where the similar products what we found on the market did not serve well enough the technical needs of the user. Among our products are Deepwell for incubation: specifications, best area where it can be used Microtubes in 96 well rack. hide...
	Laszlo Kovacs, PhD, Founder, CEO InFarmatik - Understanding Chemistry, InFarmatik Ltd., more... Dr. Laszlo Kovacs, founded InFarmatik in 1994 subsequently InFarmatik Inc. in 2003 and has served as President, Chief Executive Officer since 1999. He is co-founder and Chief Business Officer of MediMass, an MS-based real-time life tissue chemical fingerprinting company. At InFarmatik Dr. Kovacs invented a novel combinatorial chemistry instrument, the thermal gradient reactor. Prior to that, he was Vice President and Director of Chemistry at ComGenex, a pioneering Hungarian combinatorial chemistry company. InFarmatik Presentation Draft InFarmatik is a chemical company serving the life science community over 10 years. The product and service range extended from building blocks and scaffolds via experimental substances in drug discovery. Using proprietary technology InFarmatik can easily perform any related service task, such as synthesis of focused compounds, fragment design & synthesis. The proprietary technology platform is the thermal gradient reactor family which enables the company to come up with industrially viable synthesis procedure. Fragments are unique compounds designed for accelerated drug discovery by low affinity binding map of proteins of pharmaceutical interest. InFarmatik by its nature easily can compose novel structures on this field with appropriate chemistry for assembly of fragments to each other. Being a small company, InFarmatik has always needed alliances to reach its goals. The strategic alliance with ChemAxon started upon its founding, while manufacturing of larger batches of compounds made necessary to get pilot scale collaborators. hide...
	Matyas Kolsofszki (Senior Intellectual Property Asset Manager), dr. Balazs Kiss (Intellectual Property Asset Manager), Zsolt Martonfalvi (Intellectual Property Asset Manager), Projects, IP Asset Management and Technology Transfer , DDKKK INNOVATION NON-GOV. Co. more... Our aim is to build a bridge between the economic and the scientific sphere; to drive research towards the appropriate direction according to the industrial claims; to take the initiative steps in helping universities, research institutes and R&D enterprises utilizing their new born results. Our research activity consist of the development of new industrial technologies, novel -- primarily on lasers based -- instruments and methods; medicines, medical diagnostic and therapeutic procedures; elaborating and controlling methods and instruments for environment protection and for the use of renewable energy sources. We are increasing our market and research selectivity by our Intellectual Property Asset Management (IPAM). Through this, we are able to evaluate and maximize the value of our intellectual properties. University of P�cs is one of our most important partners, we are connected through scientific projects and technology transfer. We are working with the local Technology Transfer Office which is responsible for the exploitation of the university's research activity. hide...
11:45 - 12:15	Biotech in Latvia - an overview
	Juris Vanags, PhD., Research and biotechnological activities of Latvian Biomedical Research and Study Centre more... Juris Vanags graduated from the University of Latvia as an engineer of physics (1983) and got a PhD in Bioengineering in 1993. Presently he is a Managing Director of JSC, Biotehniskais centrs (manufacturer of bioreactors); Chairman of board of Latvian Biotechnology Association and associate professor of Riga Technical University (bioprocess engineering). hide...
	Andris Dishlers, Senior researcher, Research and biotechnological activities of Latvian Biomedical Research and Study Centre
12:15 - 12:45	Czech Biotech - an overview chairman: Dr. Ivana Surova
	Ivana Surowa PhD., CzechBio, the Pathway to Czech BioTech, BioTest s.r.o.more... Ivana Šurov� has been working at BioTest s.r.o., the fundig member of CzechBio. She over 20 years experience in preclinical toxicology. Since 2006, she works as Head of Business Department at BioTest s.r.o. hide...
12:45 - 14:00	Poster Session: Biotechnology R&D Projects and Scientific Services
		5 min oral poster presentation by authors
14:00 - 14:30	Lunch break
14.30 - 16.00	Wroclaw Research Centre EIT+ seminar chairman: Prof. Miroslaw Miller, CEO, WRC EIT +
	NanoBiochips
		Helena Sztajer : Biochips as a tools for food and environmental pollution analyses. Berlin Helmholtz Institute. more... Dr. Helena Sztajer was born in Poland and studied biology with specialisation in microbiology at the Wroclaw University. Afterwards she worked as scientist at the Technical University of Wroclaw where she gained her PhD in environmental microbiology. She was participating in establishing new scientific field "Biotechnology" at this University. Participation at two fellowships of UK Royal Society was helpful in her scientific development. In 1989 she has started to work as a scientist at Helmholtz Centre for Infection Research where she works at present as a principal investigator in the microbial communication group. She has written many scientific publications and took an active part in many international conferences and seminars. For her achievements she received numerous awards for example last year from the American Science Foundation. Biochips are tools for novel diagnosis and analysis. Helena Sztajer Helmholtz Centre for Infection Research, Inhoffenstra�e 7, D-38124 Braunschweig, Germany Quick and simple diagnostics in medical fields is important for successful treatment and recovery. Current diagnostics is full of complicated, time consuming and expensive methods. Many diagnostic analyses are not applicable for on-site inspections. Moreover, they require large amounts of sampling and additional conditions for storage. Demand for quick and simple analyses exists also in a food and water quality sector. Moreover, improvement would be necessary also in a cancer and virus diseases diagnostics. There is a huge demand for developing cheaper, quicker and more user friendly diagnostic tools to be able to scale down laboratory functions. Lab-on-a-chip (LOC) devices integrate and scale down laboratory functions and processes to a miniaturized chip format. Many LOC devices are used in a wide array of biomedical and other analytical applications including rapid pathogen detection, clinical diagnosis, forensic science, electrophoresis, flow cytometry, blood chemistry analysis, and protein and DNA analysis. hide...
		Zbigniew Ianelli, Janusz Sztajer . Micro Ceramic Cell Analyzer (MCCA) From Fluorescence Activated Cell Sorting to biochips. nanoBIOchips GmbH, Berlin, NanoTron Germany, more... Janusz Sztajer has obtained his MSc and Engineering degrees in Telecommunications at Wroclaw Technical University, and worked afterwards at this University at the Institute of Telecommunication and Acoustics. He has lead many interdisciplinary research projects from acoustic to microwaves, from analytical laboratory equipment to ground satellite system (meteorological, TV, and GPS). Since 1990 he has worked in Germany as a project manager in few well know international companies conducting many international projects from ground satellite equipment (UKWtechnik GmbH) to IC (Integrated Circuits) design for wireless communication (Nanotron Technology GmbH). Moreover, he has initialized standardization process for chirp technology (IEEE 802.15.4a) and was co-author of many world new products for low energy wireless networks. Janusz Sztajer has participated in a number of international projects in leading positions with many world-wide organizations and companies e.g. ESA, Eumetsat, NOAA, NATO, Atmel, STMicroelectronics and others. Zbigniew Ianelli was born in Wroclaw, Poland and studied electronics with specialization in radio communication at Wroclaw University of Technology holding a M.Sc. Eng. in Electronic Engineering. He participated in establishing new groups of scientists working in the field of satellite communication and antenna design. In the eighties he worked in one of the most modern medical centre in Poland - "Dolmed" and afterwards started to work as team leader engineer at Createc GmbH Berlin, supporting design of the small, hand-held signal computers. Createc was the first company to introduce signal computers to the market, and were therefore awarded with "Berlin Innovation" award. In the year 1992, together with Manfred Koslar, he established Nanotron Technologies GmbH in Berlin. Ianelli, who acted as Managing Director and CTO focused on development of energy efficient communication and localisation technologies profiting from his 20 years experience in microwave full-custom, mixed signal IC design, cooperation with first-class silicon foundries (STM, Atmel, IBM, Chartered, AMS), CAD/EDA vendors (Cadence, Mentor Graphics, Synopsys, Dolphin). One of his achievements was the invention and development of the Chirp technology and its worldwide acceptance. Ianelli was also the main driver behind the creation and marketability of both chip families nanoNET (Prize of "Elektronik" magazine: Product of the Year) and nanoLOC. Zbigniew Ianelli is co-inventor of more then 10 major patents in area of telecommunication. He was nominated to represent Poland during 50th EU Anniversary in the European Union Panorama project. Micro Ceramic Cell Analyser Janusz Sztajer, Nanotron Technologies GmbH, Berlin, Germany Zbigniew Ianelli, intransID, Berlin, Germany Commercializing Lab-on-Chip devices requires an interdisciplinary approach; bringing together specialists from different areas of science like: biology, medicine, physics, engineering and informatics. An interdisciplinary informal group called "NanoBiochip" was established. The first proposal of the team is to design and bring into production biochip MCCA (Micro Ceramic Cell Analyser). MCCA is a microfluidic tool combining flow cytometry - a popular technique for counting and sorting of individual cells or particles together with LTCC (Low Temperature Co-fired Ceramic) technology as micro fabrication technique. Some details concerning flow cytometry and LTCC will be presented. As a logical consequence of integration of the existing silicon technologies with novel MCCA micro fabrication it is necessary to design and develop ASIC (Application Specific Integrated Circuit) chip which will be used for controlling and processing functions of MCCA device. We will demonstrate the methodology of the ASIC development and show how to integrate it with LTCC. Moreover, possible applications of MCCA as well as integration with others technologies e.g. BAN (Body Area Network) will be presented. hide...
		Klaus Luecke: Nanodetector for catching rare cells in vivo. GILUPI, Golm, Germany, more... Klaus Luecke has a track record of nearly two decades demonstrating entrepreneurial leadership in the industries, and has broad experiences in successfully translating innovative technology into commercial opportunities. K. Luecke was appointed Chief Executive Officer of GILUPI GmbH. Previously K. Luecke was a founder and CEO of Infineon Technologies Orion GmbH, Germany, a technology company focusing on chips for the 3G Basestation. K. Luecke assumed the role of Business Unit Manager of Datacom ICs, built a business organization, including Profit & Loss responsibility that grew revenues to approximately $105 million while netting $13 Million by 2001. From 1987 to 1995 K. Luecke held various positions of increased responsibility in the global discovery organization of Siemens AG. K. Luecke holds a diploma degree in Physics from the Free University in Berlin. GILUPI GmbH Am M�hlenberg 11 14476 Potsdam OT Golm The GILUPI GmbH is a young German start-up company, which develops a medical device for isolating rare cells from blood for diagnostic tests. The patented process to produce the medical device, a detector, is based on the generation of a nanostructure and a specialized Hydrogel structure to which antibodies are bound covalently. Target cells from the blood will be enriched by the detector. The antibodies are human antibodies to avoid any side effects and especially designed to specific antigens on the target cells. The nanodetector will be applied in vivo in patients to isolate rare cells of several liters of blood flowing by the nanodetector in an arm vein. For example genetic changes can be diagnosed in the specific cells. Depending on the antibody, fetal cells or cancer cells can be fished, for DNA-Diagnostic or cancer-diagnostic. The clinical trial is started in Poznan, Poland. hide...
	Biomass and Biogas Engineering
		Frank Scholwin. Biotechnological methods for applications in biomass engineering. German Biomass Research Centre, Leipzig.more... Dr.-Ing. Frank Scholwin is currently the head of Biogas Technology Department at the German Biomass Research Centre (former Insittute of Energy and Environment) in Leipzig. He studied Environmental Engineering at the University of Rostock and then worked as a Research Fellow at the Institute of Waste Management at the University of Rostock, where he obtained his PhD in organic waste management. hide...
	New BioMedicine
		Prof.Jacek Otlewski. Biotechnology and advanced medical technologies In Wroclaw Research Center. WCB EIT+. more... Jacek Otlewski received his PhD in biochemistry at the University of Wroclaw. His habilitation was performed at the same University where he received a Professorship in 1994. Since 1996 he worked at this University as the Director of the Protein Engineering Department. In WRC EIT+ he serves as the coordinator of BioMed project. His main research interests include protein engineering, protein stability/folding, phage display, NMR, protein crystallography, cell signaling, protein interaction domains, and bionanotechnology. He has published over 100 papers. Professor Otlewski received the Marchlewski and Parnas awards from the Polish Biochemical Society and international scholarship from the HHMI. Professor Otlewski is a member of the Polish Academy of Sciences and EMBO. Wroclaw Research Centre EIT+ (WRC EIT+) is a newly established company that integrates the research potential of Lower Silesia region in Poland in the fields of biotechnology, information and communication technology, nanotechnology and advanced materials. Currently WRC EIT+ is responsible for the implementation of a project called "Biotechnologies and advanced medical technologies" (BioMed). Specific aims of the Biomed Project include: synthesis of bionanomaterials for specific medical purposes identification of molecular hallmarks of acute myeloid leukemia formulation of new antibiotics generation of supramolecular drugs based on derivates of natural phenols development of novel biodegradable polymer-drug conjugates identification of hallucinogenic substances lifestyle diseases therapy application of molecular modeling to design drugs, biocatalysts and molecular switches ribozymes as potential target of antiviral therapy searching for novel therapeutic targets in H. pylori and M. tuberculosis diagnostics and prevention of bacterial diseases advanced diagnostics of tumor diseases generation of novel nontoxic vaccines development of drugs towards periodontitis hide...
16.15 - 16.45	Pomeranian biotechnology potential - seminar chairman: Prof. Krzysztof Bielawski
	dr Heinrich Cuypers - BioCon Valley - Life Science in Mecklenburg-Vorpommern, Rostock-Greifswald, Germany.
	Prof. Krzysztof Bielawski - "BioBaltica" - strategic joint project for innovative economy in Gdansk
16.45 - 17.30	Afternoon Keynote Lecture
	Maciej Wieczorek, PhD, CEO Celon Pharma Ltd., Celon Pharma Ltd and Mabion Ltd - two different models of biotechnology company development in Poland more... Founder and CEO of a biotechnology company Celon Pharma, one of the few Polish companies developing innovative medicines. Prior to the company foundation, he was a co-owner and vice-president of the Adamed board of managment. He was responsible for product strategy, research and development, and marketing. He has patented several chemical and biotechnological drugs and has implemented a few top-selling drugs in Poland. He is also the Chairman of the Board at Mabion. hide...
20.30	BioForum 2009 Social Event, Banquet.